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TO THE EDITOR
Slug (Snai2), a highly conserved trans-
criptional repressor important in epithe-
lial-mesenchymal transformation (EMT)
in development, has also been impli-
cated in EMT-like processes during
tumor progression (Hemavathy et al.,
2000). Slug-null mice chronically expo-
sed to UVR develop a lower skin tumor
burden than wild-type mice, with fewer
aggressive spindle cell tumors (Newkirk
et al., 2007). Slug expression is tran-
siently induced in keratinocytes by UVR
and Slug expression is persistently
elevated in UVR-induced skin tumors
(Newkirk et al., 2007; Kusewitt et al.,
2009). Slug expression is regulated both
at the transcriptional and post-transla-
tional levels, and there are conflicting
reports about the role of the p53 tumor
suppressor in this regulation, as dis-
cussed below. In the present studies,
we investigated the relationship bet-
ween Slug and p53 expression in
UVR-exposed skin and UVR-induced
skin tumors by immunohistochemistry
using a specific anti-Slug antibody (Cell
Signaling, Danvers, MA), the CM5 anti-
body (Leica Microsystems, Buffalo
Grove, IL) that recognizes all forms of
p53, and the PAb240 antibody (Novus,
Littleton, CO) that recognizes p53 in
the unfolded conformation assumed by
many mutant forms. Animal studies
were performed in accordance with all
applicable state and national animal
welfare guidelines.
Several studies have suggested that
wild-type p53 suppresses Slug expres-
sion and enhances Slug degradation
(Wang et al., 2009; Rinon et al., 2011;
Zhang et al., 2011); however, we
demonstrated that induction of wild-
type p53 by UVR in keratinocytes did
not prevent concurrent Slug induction.
In the epidermis of wild-type 129 mice
exposed 1 time to 4,800 J m2 UVR and
harvested 24 hours after exposure, both
Slug and p53 were expressed predomi-
nantly in basal keratinocytes, with some
nuclei clearly expressing high levels of
both p53 and Slug (Figure 1).
Slug has been reported to be posi-
tively regulated by p53 in hematopoietic
cells in response to ionizing radiation
(Wu et al., 2005). To determine whether
Slug is a p53 target gene, we quanti-
fied Slug expression in p53-null mice
(Donehower, 1996) following a single
exposure to 2,400 J m 2 UVR. We
observed no significant difference in
the number of Slug-positive nuclei in
the unexposed skin of p53-null FVB
mice compared to wild-type FVB skin
(Figure 2a). Moreover, in both wild-type
and p53-null mice, UVR exposure signi-
ficantly (Pp0.05) enhanced Slug
expression, and there was no significant
difference between Slug induction in
wild-type versus p53-null epidermis
(Figure 2a). Thus, wild-type p53 was
not required for Slug induction by UVR.
A number of reports indicate that
wild-type p53 suppresses while mutant
p53 enhances Slug expression (Wang
et al., 2009; Roger et al., 2010; Rinon
et al., 2011; Zhang et al., 2011). We
therefore examined the relationship bet-
ween Slug and p53 expression in skin
lesions expressing mutant p53. After
repeated UVR exposures, hairless mice
develop focal aggregates of p53-positive
keratinocytes; many of these foci harbor
p53 mutations and some represent
precursors of squamous cell carci-
nomas (Rebel et al., 2001; Rebel et al.,
2005; de Gruijl and Rebel, 2008). Vir-
tually all UVR-induced tumors in the
skin of SKH-1 hairless mice express 1 or
more mutant p53 alleles (Melnikova
et al., 2005). We examined the skin of
five SKH-1 hairless mice exposed three
times weekly to UVR for a total of 10
weeks to induce the formation of pre-
neoplastic p53-positive foci. At the time
of killing, 20 weeks after the last UVR
exposure, UVR-exposed skin without
gross abnormalities was examined. Of
the 30 foci identified using the CM5
antibody, only 14 of these were also
immunoreactive with the PAb240 anti-
body. Examination of skin from similarly
treated mice at earlier time points
revealed that CM5-positive foci appea-
red before Pab240-positive foci were
detectable, suggesting that some CM5-
positive foci expressed stabilized wild
type rather than mutant p53. We also
examined p53 expression in a total of
32 squamous cell carcinomas and
spindle cell tumors induced by UVR in
SKH-1 mice. Four of the squamous cell
carcinomas did not express immuno-
histochemically detectable p53; the
p53 gene was likely deleted in these
tumors. Of the remaining 23 squamous
cell carcinomas, 14 expressed p53
detectable using both Pab240 and CM5
antibodies. Another nine squamous cell
carcinomas expressed p53 detectable
only with the CM5 antibody. All five
spindle cell tumors examined had adja-
cent or intermingled neoplastic epithelial
components, and all spindle cell compo-
nents were immunoreactive with both
p53 antibodies.
Slug expression in these UVR-induced
preneoplastic foci and skin tumors was
compared to p53 expression (Figure 2b).
Both p53-negative epidermis and p53-
positive preneoplastic foci in UVR-
exposed skin had significantly fewer
Slug-positive nuclei than p53-positive
epithelial tumors (Pp0.05). There was
no significant difference between non-
tumor skin, whatever the p53 status, and
p53-negative epithelial tumors or p53-
positive spindle cell tumors. Spindle
cell tumors had significantly lower Slug
expression than CM5-postive epithe-
lial tumors (Pp0.05), but did not differ
significantly from PAb240-positiveAccepted article preview online 5 September 2013; published online 10 October 2013
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epithelial tumors. P53-positive epithelial
tumors expressed higher levels of Slug
than p53-positive preneoplastic foci and
there was reduced expression of Slug in
p53-positive spindle cell tumors. Thus, it
appeared that p53 mutation was not the
critical factor driving Slug expression
during skin tumor progression.
Our results failed to demonstrate a
relationship between Slug and p53
expression in acutely UVR-exposed
skin, UVR-induced preneoplastic foci,
or UVR-induced skin tumors. Activation
of wild-type p53 did not prevent Slug
induction, p53 was not required for
UVR induction of Slug, and mutant
p53 expression did not enhance Slug
expression. Indeed, in tumors, expres-
sion of mutant p53 detectable with
pAB240 or complete absence of p53
expression was actually associated with
somewhat decreased Slug expression.
Our findings are consistent with a recent
report showing no correlation bet-
ween p53 and Slug immunoreactivity
in human squamous cell carcinomas
(Chen et al., 2013) and suggest that the
relationship between Slug expression
and p53 status in vivo requires addi-
tional investigation.
Slug interactions with the p53 protein
are believed to be mediated via Mdm2,
with formation of a wild-type p53–
Mdm2–Slug complex leading to degra-
dation of Slug (Wang et al., 2009). How-
ever, the relationship between Slug and
Mdm2 expression is also unresolved.
Some studies have shown that decrea-
sed Mdm2 expression is correlated with
increased Slug expression (Kim et al.,
2010; Wu et al., 2013). On the other
hand, another study indicates that
Mdm2 actually enhances Slug mRNA
expression, although Mdm2 increases
Slug protein levels only in the absence
of wild-type p53 (Jung et al., 2013).
Studies in Mdm2 knockout mice simi-
lar to those performed in the present
study in p53 knockout mice will be
required to determine the interrelation-
ship of Mdm2 and Slug in vivo.
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Figure 1. Slug and p53 are co-expressed in UVR-exposed skin. Wild-type 129 mice were exposed to
4,800 J m 2 UVR obtained from UVB sunlamps that emitted wavelengths in the 290–340 nm range,
with peak emission at 310 nm. Skin was collected 24 hours after exposure. Adjacent sections were
stained for Slug (upper panel) and for p53 using the CM5 antibody (lower panel). Arrowheads indicate
an area in which a number of cells are immunopositive for both Slug and p53. These findings are
representative of those in several 129 mice. Scale bar¼ 100mm.
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Figure 2. Slug induction by UVR is independent of p53 status. (a) Wild-type and p53-null mice were
exposed to 2,400 J m2 UVR; skin was collected 24 hours later. Asterisks indicate significantly elevated
Slug-positive nuclei/mm in UVR-exposed versus unexposed epidermis (Mann–Whitney). (b) For
p53-positive foci, SKH-1 hairless mice were exposed to 2,240 J m 2 UVR three times weekly for 10 weeks,
with skin harvested 20 weeks later. For skin tumors, SKH-1 mice were exposed to 2,240 J m2 UVR
three times weekly for 25 weeks. Morphology is indicated as N (p53-negative skin), F (preneoplastic foci),
E (epithelial tumor), or S (spindle cell tumor). Asterisks indicate a significant difference in Slug-positive
nuclei/mm2 compared with p53-negative skin and preneoplastic foci (*) or to CM5-positive tumors
(** analysis of variance).
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TO THE EDITOR
Oculocutaneous albinism (OCA) is an
autosomal recessive disorder character-
ized by hypomelanosis of the skin, hair,
and eyes, associated with reduced
visual acuity, nystagmus, and photopho-
bia (Tomita and Suzuki, 2004). Its
worldwide prevalence is approximately
1:17,000 (Witkop, 1979). Hypopigmen-
tation or complete lack of pigmentation
is caused by a deficiency involving the
production, metabolism, or distribution
of melanin, the main pigment respon-
sible for skin coloration. Diagnosis is
based on clinical findings of hypopig-
mentation of the skin and hair, in
addition to the characteristic ocular
symptoms. OCA can be isolated or asso-
ciated with other anomalies in syndro-
mic forms (Tomita and Suzuki, 2004).
Mutations of the TYR, OCA2, TYRP1,
and SLC45A2 genes have been
associated with non-syndromic forms
of OCA (OCA1–4, respectively). As
these four genes do not account for all
non-syndromic OCA, it has long been
hypothesized that other genes might be
involved. To date, more than 125 genes
have been involved in pigmentation
regulation, and many of them (at least
25) affect the biogenesis or function of
melanosomes. Several genes encoding
melanosomal proteins including TYRP2,
SLC24A5, SILV, RAB7, and RAB38 have
been considered as good candidates
for OCA. However, until recently, no
pathological mutations of these genes
had been reported in human OCA pati-
ents (Suzuki et al., 2003, Hutton and
Spritz, 2008, Grnskov et al., 2009,
Mondal et al., 2012). Very recently,
two new OCA genes were uncovered.
Mutations of C10orf11 were identified
in a family from the Faroe Islands and in
a Lithuanian patient (Grnskov et al.,
2013), and mutations of SLC24A5 were
found in a Chinese patient presenting
with non-syndromic OCA (Wei et al.,
2013). In addition, an OCA locus was
mapped to 4q24 in a consanguineous
Pakistani family, but the gene has not
yet been described (Kausar et al., 2012).
We analyzed 399 patients with non-
syndromic OCA and found that 36%
were OCA1, 25% had mutations in
OCA2, 2% were OCA3, and 11%
were caused by mutations in SLC45A2
(OCA4). An additional 6% of patients
had mutations in GPR143 (OA1) and
1% in HPS1. Six percent of patients had
a single heterozygous mutation in one
gene, and in 13% no mutation in the
known genes was identified (our unpub-
lished data). Subsequently, we sequen-
ced the nine exons of the SLC24A5 gene
in 22 OCA patients without mutations
in any of the known genes (OCA1–4,
OA1, and HPS1 genes) and foundAccepted article preview online 28 August 2013; published online 3 October 2013
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